Your Environment. Your Health.

Skip Navigation

Selected Publications

Neuropharmacology Group

  1. Qin LY, Liu Y, Hong JS, Crews FT. NADPH oxidase and aging drive microglial activation, oxidative stress and dopaminergic neurodegeneration following systemic LPS administration. Glia, 2013 (in press).
  2. Zhou H, Liao JY, Aloor J, Nie H, Wilson BC, Fessler MB, Gao HM, Hong JS.  CD11b/CD18 (Mac-1) is a novel surface receptor for extracellular double-stranded RNA to mediate cellular inflammatory responses. J Immunology 190(1):115-125, 2013.[Abstract ]
  3. Gao HM, Zhou H, Hong JS. NADPH oxidases: novel therapeutic targets for neurodegenerative diseases. Trends Parmacol Sci. 33(6):295-303, 2012.[Abstract ]
  4. Hu X, Zhou H, Zhang D, Yang SF, Qian L, Wu HM, Chen P, Wilson B, Gao HM, Lu RB, Hong JS. Clozapine protects dopaminergic neurons from inflammation-induced damage by inhibiting microglial overactivation.  J Neuroimmune Pharmacol. 7(1):187-201, 2012.[Abstract ]
  5. Chen SH, Wu HM, Ossola B, Schendzielorz N, Wilson BC, Chu CH, Chen SL, Wang Q, Zhang D, Qian L, Li X, Hong JS, Lu RB. Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage. Br J Pharmacol. 165(2):494-505, 2012.[Abstract ]
  6. Zhou H, Zhang F, Chen SH, Zhang D, Wilson B, Hong JS,Gao HM. Rotenone activates phagocyte NADPH oxidase through binding to its membrane subunit gp91phox. Free Radic Biol Med. 52(2):303-313, 2012.[Abstract ]
  7. Qian L, Wu HM, Chen SH, Zhang D, Ali SF, Peterson L, Wilson B, Lu RB, Hong JS, Flood PM. Beta2-adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway. J Immunol. 186(7):4443-4454, 2011.[Abstract ]
  8. Gao HM, Zhang F, Zhou H, Kam W, Wilson B, Hong JS. Neuroinflammation and α-synuclein dysfunction potentiate each other driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease. Environ Health Perspect. 119(6):807-814, 2011.[Abstract ]
  9. Gao HM, Hong JS. Gene-environment interactions: key to unraveling the mystery of Parkinson's disease. Prog Neurobiol. 94(1):1-19, 2011.[Abstract ]
  10. Gao, H.M., Zhou, H., Zhang, F., Wilson, B.C., Kam, W. and Hong, J.S. HMGB1 Acts on Microglia Mac1 to Mediate Chronic Neuroinflammation That Drives Progressive Neurodegeneration. The Journal of neuroscience. 31(3):1081-1092, 2011.[Abstract ]
  11. Levesque S, Wilson B, Gregoria V, Thorpe LB, Dallas S, Polikov VS, Hong JS, Block ML.  Reactive microgliosis: extracellular micro-calpain and microglia-mediated dopaminergic neurotoxicity. Brain 133(Pt 3):808-821, 2010.[Abstract ]
  12. Zhang F, Qian L, Flood PM, Jin Shi JS, Hong JS, Gao HM. Inhibition of IkappaB kinase-beta protects dopamine neurons against lipopolysaccharide-induced neurotoxicity. J Pharmcol Exp Ther. 333(3):822-833, 2010.  [Abstract ]
  13. Zhang F, Shi JS, Zhou H, Hong JS, Gao HM. Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions. Mol Pharmacol. 78(3):466-477, 2010.[Abstract ]
  14. Luo L, Rodriguez E, Jerbi K, Lachaux JP, Martinerie J, Corbetta M, Shulman GL, Piomelli D, Turrigiano GG, Nelson SB, Joels M, de Kloet ER, Holsboer F, Amodio DM, Frith CD, Block ML, Zecca L, Hong JS, Dantzer R, Kelley KW, Craig AD. Ten years of Nature Reviews Neuroscience: insights from the highly cited. Nat Rev Neurosci. 11(10):718-726, 2010.  [Abstract ]
  15. Qian L, Flood PM, Hong JS.  Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy. J Neural Transm. 117(8):971-979, 2010.[Abstract ]
  16. Wu HM, Tzeng NS, Qian L, Wei SJ, Hu X, Chen SH, Rawls SM, Flood P, Hong JS, Lu RB. Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation.  Neuropsychopharmacology 34(10): 2344-2357, 2009.[Abstract ]
  17. Zhang D, Hu X, Qian L, Wilson B, Lee C, Flood P, Langenbach R, Hong JS. Prostaglandin E2 released from activated microglia enhances astrocyte proliferation in vitro. Toxicol Appl Pharmacol. 238(1):64-70, 2009.[Abstract ]
  18. Qian, L., Wei, S-J, Zhang, D., Hu, X., Xu, Z., Wilson, B., El-Benna, J., Hong, J.S. and Flood, P.M. Potent anti-inflammatory and neuroprotective effects of TGFb1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia. J Immunol. 181(1):660-668, 2008.[Abstract ]
  19. Block, M. Zecca, L. O’Callahan, J. and Hong, J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanism. Nature Rev Neurosci. 8(1):57-69, 2007. [Abstract ]
  20. Zhang W, Wang T, Liu J, Wilson B, Meng Y, Ali S, Kim H, Zhang W, Hong JS. 3-Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP-elicited dopaminergic neurodegeneration both in vivo and in vitro. FASEB J. 20(14):2496-2511, 2006.[Abstract ]
  21. Chen, P., Peng, G, Li, G., Yang, S., Wu, X., Wang, C., Wilson, B., Lu, R., Gean, P., Chuang, D. and Hong, J.S. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol Psychiatry 11(12): 1116-1125, 2006. [Abstract ]
  22. Zhang, W, Wang, T, Pei, Z, Meng, Y., Wu, X, Wilson, B, Zhang, W, Hong, JS and Zhang, J. Aggregated a-synuclein activates microglia: a process leading to disease progression in Parkinson’s disease. FASEB J. 19(6): 533-542, 2005. [Abstract ]
  23. Qin, L., Block, M., Liu, Y., Bienstock, R., Pei, Z., Zhang, W., Wu, X., Wilson, B., Burka, T. and Hong, J.S.: Microglial NADPH oxidase is a novel target for femtomolar neuroprotection against oxidative stress. FASEB J. 19: 550-557, 2005. [Abstract ]
  24. Zhang, W, Qin, L, Wang T, Wei S. Gao H. Liu J, Wilson B, Liu B, Zhang W, Kim H, and Hong JS. 3-Hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity. FASEB J. 19(3): 395-397, 2005. [Abstract ]
  25. Qin L, Liu Y, Wang T, Wei S, Block M, Wilson B, Liu B. and Hong JS. NADPH oxidase mediates LPS-induced neurotoxicity and pro-inflammatory gene expression in activated microglia. J Biol Chem. 279(2):1415-1421, 2004. [Abstract ]
  26. Liu B. and Hong JS. Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ Health Perspect. 111(8): 1065-1073, 2003. [Abstract ]
  27. Gao H, Liu B, Zhang W, and Hong JS. Novel anti-inflammatory therapy for Parkinson’s disease. Trends Pharmacol Sci. 24(8):395-401, 2003.[Abstract ]
  28. Gao H, Liu B, and Hong JS. Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons. J Neurosci. 23(15): 6181-6187, 2003. [Abstract ]
  29. Gao H, Hong JS, Zhang W, Liu B. Synergistic dopaminergic neurotoxicity of pesticide rotenone and inflammagen LPS: relevance to the etiology of Parkinson’s disease. J Neurosci. 23:1228-1236, 2003.[Abstract ]
  30. Liu B. and Hong JS. Role of microglial activation in inflammation-mediated neurodegenerative diseases: study of mechanism and strategies for therapeutic intervention. J Pharma Exp Ther. 304(1): 1-7, 2003. [Abstract ]
  31. Gao H, Jiang J, Wilson B, Zhang W, Hong JS, Liu B. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J Neurochem. 81(6): 1285-1297, 2002. [Abstract ]
  32. Gao H, Hong JS, Zhang W, Liu B. Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J Neurosci. 22(3): 782-790, 2002. [Abstract ]
  33. Liu B, Qin L, Yang S, Wilson B, Liu Y, Hong, JS. Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage. J Pharm Exp Ther. 298(3): 1133-1141, 2001. [Abstract ]
  34. Kim WG, Wilson BC, Jeohn GH, Hong JS. Differential susceptibility of neurons in different brain regions in lipopolysaccharide (LPS)-induced neurotoxicity. J Neurosci. 20(16): 6309-6316, 2000. [Abstract ]

Back to Top